Miguel joined Amarin in 1987, at the very beginning of the company’s work in transdermal systems. He has extensive experience in preclinical studies, clinical research, and biostatistics, which allowed him to specialize in protocol design and clinical study monitoring. As Clinical Research Manager, he ensures every study complies with international standards of ethics, quality, and good clinical practice. He has coordinated and supervised Phase I (bioavailability, bioequivalence, adhesion, irritation) and Phase IIa (early efficacy and safety) studies in Argentina and abroad, collaborating with partner companies on protocol reviews. His leadership is defined by rigor, organization, and a passion for continuous improvement .